Evidence map›Paper›PMID 39163514›Full record

ArticleJournal of cellular and molecular medicine2024

Genetic variants of m

Shuyan Liu, Jianxu Li, Moqin Qiu, Yingchun Liu, Qiuping Wen, Qiuling Lin, Yanji Jiang, Zihan Zhou, Xiumei Liang, Xiaoxia Wei and 2 more

Abstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Genetic variants of mJournal of cellular and molecular medicine · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shuyan LiuGuangxi Medical University, Nanning, Guangxi, China.
Jianxu LiDepartment of Radiation Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Moqin QiuDepartment of Respiratory Oncology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yingchun LiuDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiuping WenDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Qiuling LinDepartment of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Yanji JiangScientific Research Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Zihan ZhouDepartment of Cancer Prevention and Control, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xiumei LiangDepartment of Disease Process Management, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Xiaoxia WeiDepartment of Clinical Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Hongping YuDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.
Peiqin ChenDepartment of Experimental Research, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China.ORCID 0009-0003-4013-8194

Funding

Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation Grant/Award Number: 2024GXNSFAA010383Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education GKE-KF202102Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education GKE-ZZ202104Natural Science Foundation of Guangxi Province 2023GXNSFBA026091Promoting Project of Basic Capacity for Young and Middle-aged University Teachers in Guangxi 2022KY0079Youth Program of Scientific Research Foundation of Guangxi Medical University Cancer Hospital YQJ2023-6
6 · The paper itself

Abstract

N

Indexed as

AdenosineCarcinoma, HepatocellularHepatitis B virusLiver NeoplasmsPolymorphism, Single NucleotideFemaleGenetic Predisposition to DiseaseGenotypeHepatitis BHumansMaleMethyltransferasesMiddle AgedPrognosisAdenosineMethyltransferasesMETTL3 protein, humanN-methyladenosinegenetic variantshepatitis B virushepatocellular carcinomam6Asurvival

Identifiers

PMID39163514
PMCPMC11335057

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.